Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Accuray Incorporated (ARAY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 385,485
  • Shares Outstanding, K 82,900
  • Annual Sales, $ 398,800 K
  • Annual Income, $ -25,500 K
  • 36-Month Beta 1.42
  • Price/Sales 0.97
  • Price/Cash Flow 0.00
  • Price/Book 8.14

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.55 +3.30%
on 04/17/17
5.20 -9.62%
on 04/11/17
-0.10 (-2.08%)
since 03/24/17
3-Month
4.55 +3.30%
on 04/17/17
6.00 -21.67%
on 02/01/17
-0.50 (-9.62%)
since 01/25/17
52-Week
4.45 +5.62%
on 12/27/16
6.39 -26.45%
on 09/30/16
-1.18 (-20.07%)
since 04/25/16

Most Recent Stories

More News
Is Accuray (ARAY) a Great Growth Stock?

Accuray (ARAY) looks like an exciting pick for investors as it is poised for strong future growth.

ARAY : 4.70 (+1.08%)
Accuray To Report Fiscal 2017 Third Quarter Financial Results On April 27, 2017

Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal third quarter ended March 31, 2017 on Thursday, April 27, 2017 after the market close. Management will host a conference call to review...

ARAY : 4.70 (+1.08%)
Accuray TomoTherapy System Starts Cancer Treatment in Africa

Accuray Inc. (ARAY) recently announced that the Radiotherapy and Medical Oncology Center of Sidi Abdellah, Algeria has finally initiated cancer treatment with the company's flagship TomoTherapy system....

HOLX : 44.43 (+0.45%)
ARAY : 4.70 (+1.08%)
SSH : 0.82 (-7.87%)
INGN : 81.18 (+0.32%)
Accuray 2017 Regional AERO Summit Brings Together Leading Oncology Specialists to Advance Cancer Patient Care

Renowned radiation oncologists, physicists, therapists and administrators from around the world joined together at the Accuray Exchange in Radiation Oncology (AERO(TM)) Users' Summit to discuss best practices...

ARAY : 4.70 (+1.08%)
First Cancer Patients in Africa Treated with the TomoTherapy® System

SUNNYVALE, California, April 11, 2017 /PRNewswire/ --

ARAY : 4.70 (+1.08%)
First Cancer Patients in Africa Treated with the TomoTherapy® System

Accuray Incorporated (NASDAQ: ARAY) announced today that the newly built Radiotherapy and Medical Oncology Center of Sidi Abdellah, Algeria is now treating cancer patients with the first TomoTherapy®...

ARAY : 4.70 (+1.08%)
Just Enough to Stay Positive

Just Enough to Stay Positive

CC : 39.90 (+1.73%)
CENX : 13.62 (+7.84%)
ARAY : 4.70 (+1.08%)
X : 31.11 (-0.29%)
DRI : 85.55 (+0.43%)
SGMS : 22.75 (+2.94%)
BGCP : 11.43 (+0.62%)
DXC : 76.13 (+0.58%)
MIK : 23.69 (-0.96%)
Watch for Accuray to Potentially Rebound After Falling 1.06% Yesterday

Accuray (NASDAQ:ARAY) traded in a range yesterday that spanned from a low of $4.60 to a high of $4.70. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $4.65 on volume...

ARAY : 4.70 (+1.08%)
Accuray and N.N. Burdenko National Scientific and Practical Center for Neurosurgery Sign Collaboration Agreement to Expand Radiosurgery Education and Training

SUNNYVALE, California, April 5, 2017 /PRNewswire/ --

ARAY : 4.70 (+1.08%)
Accuray Launches New Cancer Patient Websites

SUNNYVALE, California, March 2, 2017 /PRNewswire/ --

ARAY : 4.70 (+1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends...

See More

Support & Resistance

2nd Resistance Point 4.87
1st Resistance Point 4.78
Last Price 4.70
1st Support Level 4.63
2nd Support Level 4.57

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.